Related Experiment Videos
Clinical trial design for immunomodulatory biologics
1Division of Clinical Trial Design and Analysis, Office of Therapeutics Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland 20852-1448, USA.
Human & Experimental Toxicology
|August 3, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cyclic nucleotide phosphodiesterases.
The Journal of allergy and clinical immunology·2001
Identification of a novel cytokine, ML-1, and its expression in subjects with asthma.
Journal of immunology (Baltimore, Md. : 1950)·2001
Profiling of differential gene expression in activated, allergen-specific human Th2 cells.
Genes and immunity·2001
Interferon-beta induces selective enhancement of antigen-specific T cell responses.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2000
Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation.
Biochemical pharmacology·2000
Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts.
The Journal of pharmacology and experimental therapeutics·2000
Establishment of a rat model of bronchopulmonary dysplasia complicated with pulmonary hypertension and its potential applications.
Human & experimental toxicology·2026
Pulmonary iron oxide (Fe3O4) nanoparticle-biomolecule interactions modified during aging and metabolic syndrome disease progression.
Human & experimental toxicology·2026
Stevioside inhibits colorectal cancer progression by regulating macrophage polarization.
Human & experimental toxicology·2026
Predictive factors of severe outcome in glufosinate ammonium poisoning: A retrospective study in Vietnam.
Human & experimental toxicology·2025
Usnic Acid induces dual-pathway apoptosis in SKOV-3 ovarian cancer cells via PARP1 inhibition and MAPK pathway activation.
Human & experimental toxicology·2025
Invariant chain controls HLA-DQ folding and shapes the HLA class II proxiome.
Journal of immunology (Baltimore, Md. : 1950)·2026
Ultrasound-responsive PLGA nanoparticles co-loaded with celecoxib and catalase enhance the therapeutic efficacy of imatinib in gastrointestinal stromal tumors.
International journal of pharmaceutics·2026
Machine Learning-Guided Personalized Immunochemotherapy Strategies in Intrahepatic Cholangiocarcinoma.
JHEP reports : innovation in hepatology·2026